Effects of APOE on brain white matter microstructure in healthy adults

Neurology

Volumn 79, Issue 19, 2012, Pages 1961-1969

  Westlye, Lars T ^a,b   Reinvang, Ivar ^a,b   Rootwelt, Helge ^c   Espeseth, Thomas ^b,c  

^a UNIVERSITY OF OSLO   (Norway)

^b CENTRE FOR ADVANCED STUDY   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; ALLELE; ARTICLE; DEMENTIA; DIFFUSION TENSOR IMAGING; FAMILY HISTORY; FEMALE; FRACTIONAL ANISOTROPY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; WHITE MATTER;

EID: 84871211847     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3182735c9c     Document Type: Article

References (40)

1. Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet 2007;39:17-23.
2. Hauser PS, Narayanaswami V, Ryan RO. Apolipoprotein E: from lipid transport to neurobiology. Prog Lipid Res 2011;50:62-74.
3. Fields RD. White matter in learning, cognition and psychiatric disorders. Trends Neurosci 2008;31:361-370.
4. de Chaves EP, Narayanaswami V. Apolipoprotein E and cholesterol in aging and disease in the brain. Future Lipidol 2008;3:505-530.
5. Deary IJ, Whiteman MC, Pattie A, et al. Cognitive change and the APOE epsilon 4 allele. Nature 2002;418:932.
6. Bartzokis G, Lu PH, Geschwind DH, Edwards N, Mintz J, Cummings JL. Apolipoprotein E genotype and agerelated myelin breakdown in healthy individuals: implications for cognitive decline and dementia. Arch Gen Psychiatry 2006;63:63-72.
7. Beaulieu C. The basis of anisotropic water diffusion in the nervous system: a technical review. NMR Biomed 2002; 15:435-455.
8. Heise V, Filippini N, Ebmeier KP, Mackay CE. The APOE 4 allele modulates brain white matter integrity in healthy adults. Mol Psychiatry 2011;16:908-916.
9. Persson J, Lind J, Larsson A, et al. Altered brain white matter integrity in healthy carriers of the APOE epsilon4 allele: a risk for AD? Neurology 2006;66:1029-1033.
10. Nierenberg J, Pomara N, Hoptman MJ, Sidtis JJ, Ardekani BA, Lim KO. Abnormal white matter integrity in healthy apolipoprotein E epsilon4 carriers. Neuroreport 2005;16:1369-1372.
11. Bendlin BB, Ries ML, Canu E, et al. White matter is altered with parental family history of Alzheimer's disease. Alzheimers Dement 2010;6:394-403.
12. Honea RA, Vidoni E, Harsha A, Burns JM. Impact of APOE on the healthy aging brain: a voxel-based MRI and DTI study. J Alzheimers Dis 2009;18:553-564.
13. Ryan L, Walther K, Bendlin BB, Lue LF, Walker DG, Glisky EL. Age-related differences in white matter integrity and cognitive function are related to APOE status. Neuroimage 2011;54:1565-1577.
14. Song SK, Sun SW, Ramsbottom MJ, Chang C, Russell J, Cross AH. Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water. Neuroimage 2002;17:1429-1436.
15. Trachtenberg AJ, Filippini N, Cheeseman J, et al. The effects of APOE on brain activity do not simply reflect the risk of Alzheimer's disease. Neurobiol Aging 2012;33: 618.e61-618.e613.
16. Trachtenberg AJ, Filippini N, Ebmeier KP, Smith SM, Karpe F, Mackay CE. The effects of APOE on the functional architecture of the resting brain. Neuroimage 2012; 59:565-572.
17. Westlye LT, Walhovd KB, Dale AM, et al. Life-span changes of the human brain white matter: diffusion tensor imaging (DTI) and volumetry. Cereb Cortex 2010;20: 2055-2068.
18. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
19. Wechsler D. Wechsler Abbreviated Scale of Intelligence. San Antonio, TX: The Psychological Corporation; 1999.
20. Delis DC, Kaplan E, Kramer J. Delis-Kaplan Executive Function System. San Antonio, TX: The Psychological Corporation; 2001.
21. Aslanidis C, Schmitz G. High-speed apolipoprotein E genotyping and apolipoprotein B3500 mutation detection using real-time fluorescence PCR and melting curves. Clin Chem 1999;45:1094-1097.
22. Smith SM, Jenkinson M, Woolrich MW, et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004;23(suppl 1):S208-S219.
23. Jenkinson M, Bannister P, Brady M, Smith S. Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage 2002; 17:825-841.
24. Basser PJ, Pierpaoli C. Microstructural and physiological features of tissues elucidated by quantitative-diffusiontensor MRI. J Magn Reson 1996;111:209-219.
25. Smith SM, Jenkinson M, Johansen-Berg H, et al. Tractbased spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage 2006;31:1487-1505.
26. Smith SM, Nichols TE. Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. Neuroimage 2009;44: 83-98.
27. Wakana S, Jiang H, Nagae-Poetscher LM, van Zijl PC, Mori S. Fiber tract-based atlas of human white matter anatomy. Radiology 2004;230:77-87.
28. Fjell AM, Walhovd KB, Westlye LT, et al. When does brain aging accelerate? Dangers of quadratic fits in crosssectional studies. Neuroimage 2010;50:1376-1383.
29. Cohen J. A power primer. Psychol Bull 1992;112:155-159.
30. Kim J, Basak JM, Holtzman DM. The role of apolipoprotein E in Alzheimer's disease. Neuron 2009;63:287-303.
31. Grimmer T, Tholen S, Yousefi BH, et al. Progression of cerebral amyloid load is associated with the apolipoprotein E epsilon4 genotype in Alzheimer's disease. Biol Psychiatry 2010;68:879-884.
32. Wheeler-Kingshott CA, Cercignani M. About "axial" and "radial" diffusivities. Magn Reson Med 2009;61:1255-1260.
33. Jones DK, Cercignani M. Twenty-five pitfalls in the analysis of diffusion MRI data. NMR Biomed 2010;23:803-820.
34. Budde MD, Xie M, Cross AH, Song SK. Axial diffusivity is the primary correlate of axonal injury in the experimental autoimmune encephalomyelitis spinal cord: a quantitative pixelwise analysis. J Neurosci 2009;29: 2805-2813.
35. Saher G, Brugger B, Lappe-Siefke C, et al. High cholesterol level is essential for myelin membrane growth. Nat Neurosci 2005;8:468-475.
36. Alexander GE, Bergfield KL, Chen K, et al. Gray matter network associated with risk for Alzheimer's disease in young to middle-aged adults. Neurobiol Aging Epub 2012 Mar 8.
37. Peters A. The effects of normal aging on myelin and nerve fibers: a review. J Neurocytol 2002;31:581-593.
38. Tau GZ, Peterson BS. Normal development of brain circuits. Neuropsychopharmacology 2010;35:147-168.
39. Bartzokis G, Lu PH, Geschwind DH, et al. Apolipoprotein E affects both myelin breakdown and cognition: implications for age-related trajectories of decline into dementia. Biol Psychiatry 2007;62:1380-1387.
40. Grinberg LT, Thal DR. Vascular pathology in the aged human brain. Acta Neuropathol 2010;119:277-290.